跳至主要内容
临床试验/NL-OMON53178
NL-OMON53178尚未招募不适用

Stress-induced immune reprogramming in cardiovascular disease (STRESS-CVD) - STRESS-CVD

niversitair Medisch Centrum0 个研究点目标入组 125 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • - Age 40-70 years
  • - Heightened cardiovascular risk, defined as a moderate to high risk for CVD
  • (>7.5% 10 year ASCVD risk, according to American College of Cardiology (ACC)
  • AtheroSclerotic Cardiovascular Disease (ASCVD) risk calculator
  • (https://tools.acc.org/ASCVD-Risk-Estimator-Plus/#!/calculate/estimate/) or
  • patients with subclinical ASCVD on imaging (e.g. elevated CAC or asymptomatic
  • coronary artery stenosis).
  • - Written informed consent

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Previous cardiovascular events (stroke, TIA, myocardial infarction)
  • Heart failure
  • Auto-inflammatory or auto-immune diseases
  • Use of immunomodulating drugs
  • Severe renal failure (MDRD <30)
  • Previous vaccination within 1 months prior to study entry.
  • Current infection or clinically significant infections within 1 months before
  • participation (defined as fever >38.5).
  • Pregnancy/lactation
  • Severe psychiatric disorder.
  • Inability to undergo PET-CT scanning
  • History of hematological malignant disease
  • Documented bleeding diathesis or thrombocytopenia <50 *10e9/L

研究者

发起方
niversitair Medisch Centrum

相似试验